Global Invasive Fungal Infections Market Report 2024

Invasive Fungal Infections Global Market Report 2024 – By Disease Type (Candidaemi And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type), By Drug Type (Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Invasive Fungal Infections Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Invasive Fungal Infections Market Definition And Segments

Invasive fungal infections refer to severe diseases caused by pathogenic fungi that penetrate and spread within the body beyond the point of initial infection. These infections are characterized by the penetration of fungal organisms into deeper layers of tissue, such as the bloodstream, organs, or other body structures. Invasive fungal infection treatment typically includes using antifungal medications and surgical procedures to excise infected tissue in certain instances.

The main types of invasive fungal infections are candidemia and invasive candidiasis, intraabdominal candidiasis, cryptococcal meningitis, esophageal candidiasis, histoplasmosis acute pulmonary, and others. Candidemia and invasive candidiasis are infections caused by candida fungus that affect the blood, heart, brain, eyes, bones, or other parts of the body. These are treated with drug types such as polyenes, triazoles, echinocandins, flucytosine, and others by end users such as hospitals, homecare, specialty clinics, and others.

The invasive fungal infections market covered in this report is segmented –

1) By Disease Type: Candidemia And Invasive Candidiasis, Intra-Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type

2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type

3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

The invasive fungal infections market size has grown strongly in recent years. It will grow from $7.21 billion in 2023 to $7.58 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to global spread of infections, hematopoietic stem cell transplants, aging population, hospital-acquired infections, environmental factors.

The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.08 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to global health preparedness, public health education, novel antifungal agents, climate change impact, multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, collaborations for drug development.

Impact Of HIV Epidemic On The Invasive Fungal Infection Market

The rise in the population suffering from human immunodeficiency virus (HIV) is expected to propel the growth of the invasive fungal infection market going forward. HIV (Human Immunodeficiency Virus) infection is a virus that compromises the immune system's ability to defend against diseases and illnesses. The rising number of individuals with compromised immune systems, such as HIV (Human Immunodeficiency Virus) or AIDS (acquired immunodeficiency syndrome), increases the susceptibility to invasive fungal infections, creating opportunities for manufacturers to develop and supply specialized and more effective antifungal drugs. For instance, in July 2023, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS), the Switzerland-based United Nations program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Furthermore, there were approximately 1.3 million new HIV infections reported in 2022. Therefore, the rise in the population suffering from the human immunodeficiency virus (HIV) will drive the growth of the invasive fungal infection market.

Rising Number Of Cancer Patients Spurs Growth In Invasive Fungal Infections Market

The increasing number of cancer patients is expected to propel the growth of the invasive fungal infections market going forward. A cancer patent typically refers to a patent related to innovations, inventions, or technologies associated with cancer diagnosis, treatment, or prevention. Invasive fungal infections (IFIs) are severe and potentially life-threatening complications affecting cancer patients, especially those with weakened immune systems. For instance, in November 2022, according to the National Cancer Institute, a US-based cancer institute, by 2040, there are expected to be 26.0 million cancer survivors. The number of persons who have survived five or more years after receiving a cancer diagnosis is expected to rise by almost 30%, to 16.3 million, during the following ten years. Therefore, the increasing in number of cancer patents is driving the growth of the invasive fungal infections market.

Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK PLC, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMérieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd., F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB

The Challenge Of Drug-Resistant Fungal Strains In The Invasive Fungal Infection Market.

The rise of drug-resistant fungal strains can act as a challenge and may restrain the market's growth during the forecast period. The emergence of drug-resistant fungal strains poses a significant challenge for treating invasive fungal infections. As these strains evolve defenses to survive modern medicines, the effectiveness of antifungal drugs is compromised, making it difficult to treat patients with these infections. For instance, in March 2023, according to CIDRAP, the Center for Infectious Disease Research and Policy, a US-based center for public health and infectious disease response, there was a 95% rise in Candida auris, followed by a 59% rise in 2020. Therefore, the increase in drug-resistant fungal strains is hindering the growth of the invasive fungal infection market.

Advancements In Antifungal Drug Development And Market Competitiveness

Major companies operating in the invasive fungal infection market are focused on developing an antifungal drug such as Posaconazole to address the increasing demand for more effective and innovative treatments for fungal infections and gain a competitive edge in the market. Antifungal drugs such as Posaconazole are medications designed to treat fungal infections by inhibiting growth or killing the fungi responsible for the disease. For instance, in June 2021, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Posaconazol, a new triazole antifungal drug. It is effective against various invasive fungal diseases and is recommended as a second-line treatment for mucormycosis (black fungus). This drug is approved to prevent aspergillus and candida infections in immunocompromised patients and treat oropharyngeal candidiasis (OPC).

Pfizer's Commitment To Advancing Infectious Disease Therapies With The Acquisition Of Amplyx Pharmaceuticals

In April 2021, Pfizer Inc., a US-based pharmaceutical company, acquired Amplyx Pharmaceuticals, Inc. for an undisclosed amount. Through this acquisition, Pfizer broadens its infectious disease and anti-infectives portfolio by introducing a promising Phase 2 antifungal candidate, Fosmanogepix (APX001), designed to treat invasive fungal infections. Amplyx Pharmaceuticals, Inc. is a US-based pharmaceutical company specializing in innovative therapies for life-threatening diseases, including invasive fungal infections.

North America was the largest region in the invasive fungal infections market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the invasive fungal infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The invasive fungal infections market consists of revenues earned by entities by providing services such as diagnostic testing, clinical research and development, educational programs, and awareness campaign services. The market value includes the value of related goods sold by the service provider or included within the service offering. The invasive fungal infections market also includes sales of azoles, allylamines, and morpholines, which are used in treating invasive fungal infections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The invasive fungal infections market research report is one of a series of new reports from The Business Research Company that provides invasive fungal infections market statistics, including invasive fungal infections industry global market size, regional shares, competitors with a invasive fungal infections market share, detailed invasive fungal infections market segments, market trends and opportunities, and any further data you may need to thrive in the invasive fungal infections industry. This invasive fungal infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Invasive Fungal Infections Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $7.58 billion
Revenue Forecast In 2033 $9.08 billion
Growth Rate CAGR of 4.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Disease Type: Candidemia And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type
2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Merck And Co. Inc.; Bayer AG; Abbott Laboratories; GSK plc; Gilead Sciences Inc.; Siemens Healthineers; Mylan N.V.; Astellas Pharma Inc.; Quest Diagnostics Incorporated; Sun Pharmaceutical Industries Ltd.; BioMérieux SA; BioMarin Pharmaceutical Inc.; Xellia Pharmaceuticals; Basilea Pharmaceutica; Cidara Therapeutic Inc.; Pulmocide Ltd.; NovaBiotics Ltd; F2G Ltd.; Giner Inc.; Ciron Drugs And Pharmaceuticals Pvt. Ltd.; Hexima Limited; Scynexis Inc.; Enzon Pharmaceuticals Inc.; Matinas BioPharma Holdings Inc.; Biosergen AB
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Invasive Fungal Infections Market Characteristics

    3. Invasive Fungal Infections Market Trends And Strategies

    4. Invasive Fungal Infections Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Invasive Fungal Infections Market Size and Growth

    5.1. Global Invasive Fungal Infections Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Invasive Fungal Infections Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Invasive Fungal Infections Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Invasive Fungal Infections Market Segmentation

    6.1. Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Candidaemi And Invasive Candiasis

    Intra Abdominal Candiasis

    Cryptococcal Meningitis

    Esophageal Candidiasis

    Histoplasmosis Acute Pulmonary

    Other Disease Types

    6.2. Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Polyenes

    Triazoles

    Echinocandins

    Flucytosine

    Other Drug Types

    6.3. Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End-Users

    7. Invasive Fungal Infections Market Regional And Country Analysis

    7.1. Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Invasive Fungal Infections Market

    8.1. Asia-Pacific Invasive Fungal Infections Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Invasive Fungal Infections Market

    9.1. China Invasive Fungal Infections Market Overview

    9.2. China Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Invasive Fungal Infections Market

    10.1. India Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Invasive Fungal Infections Market

    11.1. Japan Invasive Fungal Infections Market Overview

    11.2. Japan Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Invasive Fungal Infections Market

    12.1. Australia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Invasive Fungal Infections Market

    13.1. Indonesia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Invasive Fungal Infections Market

    14.1. South Korea Invasive Fungal Infections Market Overview

    14.2. South Korea Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Invasive Fungal Infections Market

    15.1. Western Europe Invasive Fungal Infections Market Overview

    15.2. Western Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Invasive Fungal Infections Market

    16.1. UK Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Invasive Fungal Infections Market

    17.1. Germany Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Invasive Fungal Infections Market

    18.5. France Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Invasive Fungal Infections Market

    19.9. Italy Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Invasive Fungal Infections Market

    20.13. Spain Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Invasive Fungal Infections Market

    21.1. Eastern Europe Invasive Fungal Infections Market Overview

    21.2. Eastern Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Invasive Fungal Infections Market

    22.1. Russia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Invasive Fungal Infections Market

    23.1. North America Invasive Fungal Infections Market Overview

    23.2. North America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Invasive Fungal Infections Market

    24.1. USA Invasive Fungal Infections Market Overview

    24.2. USA Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Invasive Fungal Infections Market

    25.1. Canada Invasive Fungal Infections Market Overview

    25.2. Canada Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Invasive Fungal Infections Market

    26.1. South America Invasive Fungal Infections Market Overview

    26.2. South America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Invasive Fungal Infections Market

    27.1. Brazil Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Invasive Fungal Infections Market

    28.1. Middle East Invasive Fungal Infections Market Overview

    28.2. Middle East Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Invasive Fungal Infections Market

    29.1. Africa Invasive Fungal Infections Market Overview

    29.2. Africa Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Invasive Fungal Infections Market Competitive Landscape And Company Profiles

    30.1. Invasive Fungal Infections Market Competitive Landscape

    30.2. Invasive Fungal Infections Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck And Co. Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bayer AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Abbott Laboratories

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GSK plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Invasive Fungal Infections Market Other Major And Innovative Companies

    31.1. Gilead Sciences Inc.

    31.2. Siemens Healthineers

    31.3. Mylan N.V.

    31.4. Astellas Pharma Inc.

    31.5. Quest Diagnostics Incorporated

    31.6. Sun Pharmaceutical Industries Ltd.

    31.7. BioMérieux SA

    31.8. BioMarin Pharmaceutical Inc.

    31.9. Xellia Pharmaceuticals

    31.10. Basilea Pharmaceutica

    31.11. Cidara Therapeutic Inc.

    31.12. Pulmocide Ltd.

    31.13. NovaBiotics Ltd

    31.14. F2G Ltd.

    31.15. Giner Inc.

    32. Global Invasive Fungal Infections Market Competitive Benchmarking

    33. Global Invasive Fungal Infections Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Invasive Fungal Infections Market

    35. Invasive Fungal Infections Market Future Outlook and Potential Analysis

    35.1 Invasive Fungal Infections Market In 2028 - Countries Offering Most New Opportunities

    35.2 Invasive Fungal Infections Market In 2028 - Segments Offering Most New Opportunities

    35.3 Invasive Fungal Infections Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Merck And Co. Inc. Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Abbott Laboratories Financial Performance
  • Table 78: GSK plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Merck And Co. Inc. Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Abbott Laboratories Financial Performance
  • Figure 78: GSK plc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Hepatitis B Virus (HBV) Global Market Report 2024 – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Hepatitis Global Market Report 2024 – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis), By Treatment (Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hepatitis Drugs Global Market Report 2024 – By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase/NS5A Inhibitor Combinations, Hepatitis C Protease/NS5A Inhibitor Combinations, NS5A Inhibitors, Nucleotide Polymerase Inhibitors, Nucleoside Analogue Antivirals, Thrombopoiesis Stimulating Agents), By Route Of Administration (Oral, Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 – By Drug Type( Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types), By Test Type( Blood Tests, Liver Biopsy, Imaging Procedures), By End User( Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hepatitis Therapeutics Global Market Report 2024 – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024 – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Disease (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), By End Use (Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses) – Market Size, Trends, And Global Forecast 2024-2033
View Report
In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024 – By Product type (Quality Control Products, Data Management Solutions, Quality Assurance Services), By Manufacturer Type (IVD Instrument Manufacturers, Third Party Quality Control Manufacturers), By Application (Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications), By End-Users (Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Infectious Disease Diagnostics Global Market Report 2024 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing animals), By Technology (Immunodiagnostics, Molecular Diagnostic, Other Technologies), By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Point of Care, Research Institutes and Universities, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the invasive fungal infections market?

Invasive fungal infections refer to severe diseases caused by pathogenic fungi that penetrate and spread within the body beyond the point of initial infection. These infections are characterized by the penetration of fungal organisms into deeper layers of tissue, such as the bloodstream, organs, or other body structures. Invasive fungal infection treatment typically includes using antifungal medications and surgical procedures to excise infected tissue in certain instances. For further insights on the invasive fungal infections market, request a sample here

How will the invasive fungal infections market drivers and restraints affect the invasive fungal infections market dynamics? What forces will shape the invasive fungal infections industry going forward?

The invasive fungal infections market major growth driver - impact of hiv epidemic on the invasive fungal infection market. For further insights on the invasive fungal infections market, request a sample here

What is the forecast market size or the forecast market value of the invasive fungal infections market?

The invasive fungal infections market size has grown strongly in recent years. It will grow from $7.21 billion in 2023 to $7.58 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to global spread of infections, hematopoietic stem cell transplants, aging population, hospital-acquired infections, environmental factors.. The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.08 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to global health preparedness, public health education, novel antifungal agents, climate change impact, multidisciplinary approaches.. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, collaborations for drug development.. For further insights on the invasive fungal infections market, request a sample here

How is the invasive fungal infections market segmented?

The invasive fungal infections market is segmented
1) By Disease Type: Candidaemi And Invasive Candiasis, Intra Abdominal Candiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type
2) By Drug Type: Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-UsersFor further insights on the invasive fungal infections market, request a sample here

Which region has the largest share of the invasive fungal infections market? What are the other regions covered in the report?

North America was the largest region in the invasive fungal infections market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the invasive fungal infections market, request a sample here.

Who are the major players in the invasive fungal infections market?

Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK plc, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMérieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd, F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB For further insights on the invasive fungal infections market, request a sample here.

What are the key trends in the invasive fungal infections market?

Major trend in the invasive fungal infections market - Advancements In Antifungal Drug Development And Market Competitiveness. For further insights on the invasive fungal infections market, request a sample here.

What are the major opportunities in the invasive fungal infections market? What are the strategies for the invasive fungal infections market?

For detailed insights on the major opportunities and strategies in the invasive fungal infections market, request a sample here.

How does the invasive fungal infections market relate to the overall economy and other similar markets?

For detailed insights on invasive fungal infections market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the invasive fungal infections industry?

For detailed insights on the mergers and acquisitions in the invasive fungal infections industry, request a sample here.

What are the key dynamics influencing the invasive fungal infections market growth? SWOT analysis of the invasive fungal infections market.

For detailed insights on the key dynamics influencing the invasive fungal infections market growth and SWOT analysis of the invasive fungal infections industry, request a sample here.